Matsuda K, Tsutsumi M, Kanazawa T, Chihara I, et al. Limited Response to Enfortumab Vedotin-Pembrolizumab in Three Consecutive Cases of Neoadjuvant Chemotherapy-Resistant Muscle-Invasive Bladder Cancer. Int J Urol 2025;32:1712-1714.
PMID: 41189062